Nutraceutical News and Research

RSS

Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food product that provides health and medical benefits, including the prevention and treatment of disease.

Medical Care Technologies plans to focus on new business strategy in 2010

On October 6, 2009, MDCE entered into a non-binding Letter of Intent with Great Union Corporation ("GUC"), a Hong Kong corporation, with the intent to acquire ownership of certain medical care products developed by GUC.

9 Jan 2010

PanGenex adds number of CAM practitioners to national physicians' referral network

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today it has added a number of complementary alternative medicine (CAM)/holistic medical practitioners to its national physicians' referral network.

5 Jan 2010

Citicoline supplements may reduce cravings and increase satiety

The obesity crisis in the United States has now grown to epidemic proportion. And as the list of consequential health conditions and diseases continues to expand as well, there are major movements toward helping Americans lose weight.

5 Jan 2010

EquityNet Research begins independent coverage on Huifeng Bio-Pharmaceutical Technology

Huifeng Bio-Pharmaceutical Technology, Inc., a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today reported that after preliminary due diligence, including review of the company's market potential and development opportunities, EquityNet Research is initiating coverage of the company as an independent analyst.

22 Dec 2009

Shuaiyi International New Resources Development closes private placement with accredited investors for $2.5 million

Shuaiyi International New Resources Development Inc. ("Shuaiyi" or the "Company"), a leading nutraceutical company focusing on the advanced technology related to the development of engineered "Cordyceps Militaris" in China, today announced the closing of a private placement with a group of accredited investors, pursuant to which the Company issued 1 million shares of the Company's common stock at a purchase price of $2.50 per share, for an aggregate purchase price of $2.5 million.

22 Dec 2009

Biostar Pharmaceuticals to acquire a Xi'an-based medical equipment and nutrients manufacturer for $1.1M

Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced it has signed a letter of intent ("LOI') with a Xi'an-based medical equipment and nutrients manufacturer ("Acquiree") to acquire 100% of the Acquiree for $1.1 million in cash.

16 Dec 2009

Dyadic International enters into collaboration agreement with The Scripps Research Institute

Dyadic International, Inc. ("Dyadic") announced today that it has extended its collaboration with The Scripps Research Institute ("Scripps") by entering into an agreement with Scripps to re-annotate the genome of Dyadic's patented and proprietary C1 fungus ("C1").

15 Dec 2009

Nutraceutical International reports net income of $3.2M for fourth-quarter fiscal 2009

Nutraceutical International Corporation today reported results for the fiscal 2009 fourth quarter and year ended September 30, 2009. Net sales for the fiscal 2009 fourth quarter were $41.4 million compared to $40.9 million for the same quarter of fiscal 2008.

10 Dec 2009

European market for digestive health ingredients to reach $536.5 million in 2015

rowing consumer awareness of functional foods fuels demand and boosts product availability for digestive health ingredients in the EU. In 2008, digestive health was the largest product segment of the total EU approved functional food market, accounting for 68.0 per cent of sales.

9 Dec 2009

Vitamins and nutriceuticals improve memory and cognitive performance, shows study

A recent study presented at the Gerontological Society of America's 62nd Annual Scientific Meeting shows that a combination of vitamins and nutriceuticals improves memory and cognitive performance in community-dwelling adults.

8 Dec 2009

PanGenex capitalize on the immune-boosting properties of Spirulina

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that the Company is actively identifying new product development opportunities that will initially focus on the immune-boosting properties of Spirulina.

3 Dec 2009

PanGenex plans to expand its retail product line with the addition of spirulla

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has solidified plans to expand its retail product line with the addition of spirulla.

1 Dec 2009

Advitech announces merger operations with Botaneco Specialty Ingredients

Advitech Inc. ("Advitech" or the "Corporation") (TSX Venture Exchange: AVI) announced today that, further to the consolidation of its common shares on a 8-for-1 basis (the "Consolidation"), the TSX Venture Exchange Inc. (the "TSX-V") has approved the release from escrow of the previously announced acquisition of all the issued and outstanding shares of Botaneco Specialty Ingredients Inc.

27 Nov 2009

PanGenex finalizes partnership with BulovaTech Labs

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that it has finalized a strategic partnership with BulovaTech Labs, Inc., (“LABS”), a wholly-owned subsidiary of Bulova Technologies Group Inc.

16 Nov 2009

CNS Pharmaceuticals' common shares sponsored by 886 AG on the electronic trading platform Xetra

CNS PHARMACEUTICALS AG, (C35.F) a developer and marketer of patented natural nutraceutical products is pleased to announce that the Company’s common shares is sponsored by the German Securities Trading Bank 886 AG Wertpapier Handelsbank on the electronic trading platform Xetra.

13 Nov 2009

Enavail obtains an exclusive license for a portfolio of particle engineering technologies

Particle engineering company Enavail announced today that it has obtained an exclusive license from The University of Texas at Austin for a portfolio of particle engineering technologies that will be utilized for pharmaceutical, biotechnology and nutraceutical applications.

10 Nov 2009

TNS files Provisional Use Patent application on the ability of a natural organic mushroom formula

Total Nutraceutical Solutions, Inc. (TNS), announced that it has filed a Provisional Use Patent application on the ability of a proprietary natural organic mushroom formula to control oxidative stress.

9 Nov 2009

Third quarter 2009 financial results announced by SCOLR Pharma

SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.

7 Nov 2009

The Netherlands Antilles Public Health Inspectorate issues importation approval for TNS' ImmuSANO and GlucoSANO

Total Nutraceutical Solutions, Inc., announced today that it has received approval for importation of ImmuSANO™ and GlucoSANO™ from the Inspectorate of Public Health, Bureau of Pharmaceutical Affairs in Curacao, The Netherlands Antilles.

30 Oct 2009

Omnicare Clinical Research attains Rave Accredited Plus in Medidata’s ASPire to Win program for CRO's

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced that global contract research organization (CRO) Omnicare Clinical Research has attained Rave Accredited Plus, the most advanced level in Medidata’s ASPire to Win® program for CROs and other service providers.

28 Oct 2009